Platelet function parameters in management of XXXX : a case-controlled study.

@entity1 @entity1712 @entity66 @entity233 @entity6688 @entity99
AIM: To evaluate platelet function in @entity1 with a history of surgical treatment for @entity99 ( @entity66 ). METHODS: This retrospective case-controlled study was performed in a state hospital in @entity233 from January 2009 to November 2013. The @entity1 were divided into two groups: those evaluated in the preoperative period (Group 1) and those evaluated in the postoperative period (Group 2). The @entity1 groups were compared with a control group (Group 3). All three groups were evaluated using laboratory records from day 1 of the preoperative period and day 30 of the postoperative period. The haematocrit level (HTC), platelet count (PLT), mean platelet volume ( @entity6688 ), platelet distribution width (PDW), and percentage of @entity1712 ( @entity1712 ) were compared among the groups. RESULTS: Fifty-three @entity1 who had undergone surgical treatment of hepatic @entity66 and 55 healthy controls were included in the study. The mean follow-up time for all @entity1 was 45 (14-70) months. The @entity1 comprised 33 (62%) females and 20 (38%) males. The control group comprised 37 (67%) females and 18 (33%) males. The median age of the @entity1 was 48 (19-78) years, while that of the control group was 42 (16-64) years. No significant differences in the HTC, PLT, or @entity1712 were present among the groups. The @entity6688 and PDW indicated that platelet function was significantly different between Group 1 and Groups 2 and 3. Additionally, nine @entity1 had undergone previous surgical treatment for @entity66 . In a separate long-term follow-up, these @entity1 exhibited no statistically significant differences in @entity6688 or PDW between the preoperative and postoperative periods. CONCLUSIONS: @entity6688 and PDW can be used in the initial follow-up of @entity1 with hepatic @entity66 , but have limited use in long-term follow-up.
